SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-037042
Filing Date
2022-11-08
Accepted
2022-11-08 16:16:18
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rna-8k_20221108.htm   iXBRL 8-K 37593
2 EX-99.1 rna-ex991_6.htm EX-99.1 277107
3 GRAPHIC gfnzizaxnpmk000001.jpg GRAPHIC 206622
  Complete submission text file 0001564590-22-037042.txt   706909

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rna-20221108.xsd EX-101.SCH 5626
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20221108_lab.xml EX-101.LAB 19331
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20221108_pre.xml EX-101.PRE 11516
8 EXTRACTED XBRL INSTANCE DOCUMENT rna-8k_20221108_htm.xml XML 3563
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 221369110
SIC: 2834 Pharmaceutical Preparations